Shengqiang Gao

Shengqiang Gao

Auto-generated profile, based on publicly available information

Shengqiang Gao

Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2023 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
ZZzhenglin zhu
zhenglin zhu
YCYi Chen
Yi Chen
JZJing Zou
Jing Zou
SGShengqiang Gao
Shengqiang Gao
DWDandong Wu
Dandong Wu
HCHong Chen
Hong Chen
Background: High-intensity interval training (HIIT) reportedly improves bone metabolism and increases bone mineral density (BMD). The purpose of the present study was to investigate whether lactate mediates the beneficial effects of exercise on BMD, bone microarchitecture, and biomechanical properties in an established osteoporotic animal model. In addition, we hypothesized that lactate-induced bone augmentation is achieved through enhanced osteoblast differentiation and mineralization. Methods: A total of 50 female C57BL/6 mice were randomly allocated into 5 groups: the nonovariectomized group, the ovariectomized group (OVX), the HIIT group (OVX + HIIT), the HIIT with lactate transporter inhibition group (OVX + HIIT + INH), and the lactate subcutaneous injection group (OVX + LAC). After 7 weeks of intervention, bone mass, bone strength, and bone formation/resorption processes were evaluated via microcomputed tomography (micro-CT), biomechanical testing, histological analysis, and serum biochemical assays; in vitro studies were performed to explore the bone anabolic effect of lactate at the cellular level. Results: Micro-CT revealed significantly increased BMD in both the OVX + HIIT group (mean difference, 41.03 mg hydroxyapatite [HA]/cm3 [95% CI, 2.51 to 79.54 mg HA/cm3]; p = 0.029) and the OVX + LAC group (mean difference, 40.40 mg HA/cm3 [95% CI, 4.08 to 76.71 mg HA/cm3]; p = 0.031) compared with the OVX group. Biomechanical testing demonstrated significantly improved mechanical properties in those 2 groups. However, the beneficial effects of exercise on bone microstructure and biomechanics were largely abolished by blocking the lactate transporter. Notably, histological and biochemical results indicated that increased bone formation was responsible for the bone augmentation effects of HIIT and lactate. Cell culture studies showed a marked increase in the expression of osteoblastic markers with lactate treatment, which could be eliminated by blocking the lactate transporter. Conclusions: Lactate may have mediated the bone anabolic effect of HIIT in osteoporotic mice, which may have resulted from enhanced osteoblast differentiation and mineralization. Clinical Relevance: Lactate may mediate the bone anabolic effect of HIIT and serve as a potential inexpensive therapeutic strategy for bone augmentation.

20 May 2022 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
CDChengcheng Du
Chengcheng Du
PXPengcheng Xiao
Pengcheng Xiao
SGShengqiang Gao
Shengqiang Gao
SCShengwen Chen
Shengwen Chen
BCBowen Chen
Bowen Chen
CZChen Zhao
Chen Zhao
Fluorosis is still endemic in at least 25 countries around the world. In this study, we investigated the effect of high fluoride intake on fracture healing. Our in vitro experiments found that fluoride inhibited the osteogenic and angiogenic differentiation of MSCs in a dose-dependent manner. By constructing a bone fracture model, we found that high fluoride intake influences bone fracture by attenuating endochondral ossification and angiogenesis. In the mechanism, we clarified that high fluoride inhibits M2 differentiation rather than M1 differentiation in the fracture area, which may contribute to the delayed healing of the fracture. These findings provide an essential reference for the clinical treatment of bone fracture patients with a history of high fluoride intake or skeletal fluorosis patients.

12 June 2023 in Journal of Orthopaedic Translation
Verified
Journal Article
Open access
ZZZhenglin Zhu
Zhenglin Zhu
SGShengqiang Gao
Shengqiang Gao
HZHui Zhu
Hui Zhu
YCYi Chen
Yi Chen
DWDandong Wu
Dandong Wu
HCHong Chen
Hong Chen
Emerging studies have suggested an essential role of fibroblast metabolic reprogramming in the pathogenesis of arthrofibrosis. The metabolic modulator metformin appears to be a therapeutic candidate for fibrotic disorders. However, whether metformin could alleviate arthrofibrosis has not been defined. In this study we have determined if treatment with metformin has beneficial effect on arthrofibrosis and its underlying mechanism. Articular capsule samples were collected from patients with/without arthrofibrosis to perform gene and protein expression analysis. Arthrofibrosis animal model was established to examine the anti-fibrotic effect of metformin. Cell culture experiments were conducted to determine the mechanism by which metformin inhibits fibroblast activation. We found that glycolysis was upregulated in human fibrotic articular capsules. In an arthrofibrosis animal model, intra-articular injection of metformin mitigated inflammatory reactions, downregulated expression of both fibrotic and glycolytic markers, improved range of motion (ROM) of the joint, and reduced capsular fibrosis and thickening. At the cellular level, metformin inhibited the activation of fibroblasts and mitigated the abundant influx of glucose into activated fibroblasts. Interestingly, metformin prompted a metabolic shift from oxidative phosphorylation to aerobic glycolysis in activated fibroblasts, resulting in the anti-fibrotic effect of metformin. Metformin decreased glycolysis, causing a metabolic shift toward aerobic glycolysis in activated fibroblasts and has beneficial effect on the treatment of arthrofibrosis. The translational potential of this article: The findings of this study demonstrated the therapeutic effect of metformin on arthrofibrosis and defined novel targets for the treatment of articular fibrotic disorders.

5 July 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
ZZzhenglin zhu
zhenglin zhu
SGShengqiang Gao
Shengqiang Gao
HZHui Zhu
Hui Zhu
YCYi Chen
Yi Chen
DWDandong Wu
Dandong Wu
HCHong Chen
Hong Chen
Background Emerging studies have suggested an essential role of fibroblast metabolic reprogramming in the pathogenesis of arthrofibrosis. The metabolic modulator metformin appears to be a good candidate for fibrotic disorder treatment. We sought to determine the beneficial effect of metformin on arthrofibrosis and the underlying mechanism of action of this drug. Methods Shoulder capsule samples were collected from patients with/without frozen shoulder to perform gene and protein expression analysis. Arthrofibrotic animal model was established to examine the anti-fibrotic effect of metformin. In vitro cell culture experiments were conducted to determine the mechanism by which metformin inhibits fibroblast activation. Results Clinical sample analysis demonstrated that glycolysis was upregulated in human fibrotic joint capsules. In an arthrofibrotic animal model, metformin improved the joint range of motion, reduced capsular fibrosis and thickening, mitigated inflammatory reactions, and downregulated both fibrotic and glycolytic markers. The results of gene and protein expression analysis showed that metformin effectively inhibited TGF-β induced fibroblast activation. The metabolomics study confirmed a metformin-induced metabolic shift from oxidative phosphorylation (OXPHOS) to aerobic glycolysis in fibroblasts. Importantly, the inhibitory effect of metformin on fibroblast activation was mediated by metabolic reprogramming of fibroblasts. Interestingly, fibroblast-derived lactate induced M2-like macrophage polarization and diminished the inflammatory reaction. Conclusions Metformin is a potential treatment alternative for arthrofibrosis, and antifibrotic effect of the drug involves metabolic reprogramming toward aerobic glycolysis in fibroblasts and lactate-induced M2-like macrophage polarization.

24 October 2026 in Genes & Diseases
Verified
Journal Article
Open access
SGShengqiang Gao
Shengqiang Gao
PZPiao Zhao
Piao Zhao
TDTingting Du
Tingting Du
YYYu Ye
Yu Ye
SCShengwen Cheng
Shengwen Cheng
Junyi LiaoJunyi Liao
Junyi Liao